Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...

Humira (adalimumab) is a prescription drug used to treat hidradenitis suppurativa (HS). It helps reduce moderate to severe symptoms of this condition. Humira is also available in biosimilar forms ...

Humira (adalimumab) has potential interactions with other medications and certain vaccines. For example, Humira can interact with prednisone, warfarin, and live vaccines for measles, mumps, and ...

In the study, participants (N=371) were treated with Humira during a lead-in period of 13 weeks. Patients who achieved at least a 50% reduction in Psoriasis Area and Severity Index (PASI50 ...

After years of patent protection, biosimilars for Humira are set to enter the US market in 2023. The arrival of these drugs has been widely anticipated throughout the healthcare industry.

With this approval, Yuflyma is now fully interchangeable with the reference product, Humira (adalimumab), across all marketed dosage forms and strengths. Yuflyma is a high-concentration ...

As our data shows, on average, patients paid more than four times as much out of pocket per month for Humira compared to Hadlima,” said Jon Martin, U.S. commercial lead, biosimilars and ...

SPRINGFIELD, Mass. (WWLP) – Health New England announced Monday that it will shift coverage of the biologic drug Humira to more affordable FDA-approved biosimilars starting next month for ...

29,385 people played the daily Crossword recently. Can you solve it faster than others?29,385 people played the daily Crossword recently. Can you solve it faster than others?

‘Sustainable’ or ‘eco-friendly’ packaging is not new. But now it is proliferating, and the sector is expected to boom in the coming years. According to Grand View Research, the eco-friendly packaging ...

and Organon & Co. (NYSE: OGN) have announced the U.S. Food and Drug Administration’s (FDA) approval of HADLIMA™ (adalimumab-bwwd) as an interchangeable biosimilar to Humira® (adalimumab).

Packaging science goes far beyond mere protection and containment. It's a bridge between products and consumers, serving as a powerful tool for marketing, sustainability, and innovation. This is where ...